|
ETNK1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.956200E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.900000E-03 |
| Normal-vs-Stage2 |
8.186000E-01 |
| Normal-vs-Stage3 |
6.732400E-02 |
| Normal-vs-Stage4 |
3.667400E-01 |
| Stage1-vs-Stage2 |
4.824600E-01 |
| Stage1-vs-Stage3 |
9.357000E-01 |
| Stage1-vs-Stage4 |
9.229400E-01 |
| Stage2-vs-Stage3 |
4.846000E-01 |
| Stage2-vs-Stage4 |
6.770800E-01 |
| Stage3-vs-Stage4 |
8.841400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.131510E-02 |
| Normal-vs-AfricanAmerican |
5.698800E-01 |
| Normal-vs-Asian |
9.286300E-02 |
| Caucasian-vs-AfricanAmerican |
2.475200E-01 |
| Caucasian-vs-Asian |
8.052600E-01 |
| AfricanAmerican-vs-Asian |
5.751600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.726300E-02 |
| Normal-vs-Female |
1.387220E-01 |
| Male-vs-Female |
9.426600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.210000E-02 |
| Normal-vs-Extreme_Weight |
9.799000E-03 |
| Normal-vs-Obese |
3.477400E-01 |
| Normal-vs-Extreme_Obese |
3.310400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.413800E-01 |
| Normal_Weight-vs-Obese |
2.581800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.656000E-01 |
| Extreme_Weight-vs-Obese |
2.521000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.456800E-01 |
| Obese-vs-Extreme_Obese |
7.037400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.505400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.463000E-01 |
| Normal-vs-Age(61-80Yrs) |
9.302800E-03 |
| Normal-vs-Age(81-100Yrs) |
3.475300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.701600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.320810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.758100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.923700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.099600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.783760E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.752800E-01 |
| Normal-VS-Type2 PRCC |
1.84250000034858E-07 |
| Normal-VS-KIRP CIMP |
3.340000E-01 |
| Normal-VS-Unclassified PRCC |
5.892600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.79430000027503E-07 |
| Type1 PRCC-VS-KIRP CIMP |
4.491400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.462600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.427580E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.128480E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
6.585000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.200390E-03 |
| Normal-vs-N1 |
3.573200E-01 |
| Normal-vs-N2 |
3.525200E-01 |
| N0-vs-N1 |
2.443000E-01 |
| N0-vs-N2 |
5.667800E-01 |
| N1-vs-N2 |
9.693000E-01 |
|
|
